Page 4 - Diagnostics Inc News Today

/PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...

Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) CEO Jack Phillips sold 26,545 shares of the business’s stock in a transaction on Friday, April 12th. The shares were sold at an average price of $0.86, for a total value of $22,828.70. Following the completion of the sale, the chief executive officer now owns 129,726 shares […]

In clinical trials of cancer screening, the incidence of late-stage cancer works as well as cancer-specific mortality as an endpoint for some cancers but not others.

Ribbon-cutting included support from Mayor Wood of South Salt Lake and other dignitaries SALT LAKE CITY, April 12, 2024 /PRNewswire/ -- Co-Diagnostics, Inc.  , a molecular diagnostics company with...

The project also received funding from Elanco Animal Health.

Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The

Accelerate Diagnostics Announces 510 Submission of the Accelerate Arc™ System to the FDA Apr 09, 2024 Enabling rapid, automated microbial identification...

Marketresearch.biz reports that the Disease Prevention Market size is expected to be worth around USD 792.7 Bn by 2032 from USD 221.0 Bn in 2022, growing at a CAGR of 14.0% during the forecast period from 2023 to 2032.Overview of the Disease Prevention MarketThe Disease Prevention Market focuses on strategies, inter...

Team will identify which ASFV proteins induce protective immune responses, the optimal vaccine dose and a way to differentiate infected from vaccinated pigs.